OPTN optinose.com: Operating Profitability

OptiNose (OPTN) - corporate logo

Aggressive marketing is temporarily reducing gross revenue, limiting the operating leverage of OptiNose, Inc. (OPTN). The operating margin illustrates current profit dynamics, where -19.40 captures the real-time state of the parameter. Efficiency is sustained by robotic component assembly, which eliminates manual labor. Additionally, diversified plastic supplies guarantee assembly stability and high margins for distribution networks.

OptiNose (OPTN): Operating Return on Sales from 07/04/2022 to 05/31/2025

Metric breakdowns and analytics for OptiNose (OPTN)

- share price and consensus valuation forecast:
- company stock capitalization data:
Fundamental company valuation:OptiNose Corp, OPTN
Finished products of optinose.com

To minimize long-term risks, investors should evaluate cost management efficiency via the operating profit margin. By analyzing the operating profitability trend of OptiNose, Inc. (OPTN), one can understand how the implementation of environmental standards and the optimization of ENT drug logistics impact the net business efficiency before taxes and interest, thereby determining the asset's ultimate investment attractiveness.

Competitor analysis

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Margin BHST|EXOZ - Operating Return on Sales|Oramed - Operating Sales Margin|Entera Bio Ltd. (ENTX) - Operating Return on Sales|HYFT - Operating Profitability|ABVC: Operating Profitability|CPIX: Operating Margin|Quantum BioPharma Ltd. - Operating Profit Rate|FGEN (FibroGen Corp) - Operating Margin|Telomir Pharma (TELO) - Profitability of Operations|Operating Profitability Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operating Profit Rate|Operating Profitability Rallybio Corporation RLYB|LEXX: Return on Sales by Operating Profit|PULM - Operating Profitability|Operating Profit Rate PTHL (Pheton Holdings)|Aptorum (APM) - Operating Profitability|LYRA (Lyra Therapeutics) - Operating Profitability|Operating Profitability Impact BioMedical Inc|TNF Pharmaceuticals - Operating Profit Margin|Operating Margin YCBD|Operating Margin PainReform Ltd. (PRFX)|Operating Profitability Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Operating Profit Margin|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.